Form 8-K Aevi Genomic Medicine, For: Jan 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Aevi (GNMX) PT Lowered to $0.20 at Jefferies
January 3, 2019 12:35 PM ESTJefferies analyst Roger Song lowered the price target on Aevi (NASDAQ: GNMX) to $0.20 (from $1.25) while maintaining a Hold rating.
... More